Don Crane is President and CEO of America’s Physician Group, the nation's only professional association exclusively representing capitated, coordinated care organizations, and is a leading voice promoting the interests of physicians practicing accountable care across the nation. APG consists of approximately 200 multi-specialty medical groups and IPAs that provide medical care to over 16 million patients across 40 states, the District of Columbia and Puerto Rico.

Mr. Crane is in the forefront of national public policy advocacy on behalf of accountable care organizations across the country as they make the journey from volume to value and move into risk-based alternative payment models. He is the lead producer and moderator of APG's nationally acclaimed healthcare conferences.

A seasoned healthcare attorney, Mr. Crane practiced healthcare law for over 30 years and served as corporate counsel for several major integrated health systems. Mr. Crane speaks regularly on healthcare issues to a wide variety of physician groups, hospital boards, and academic meetings. He has been a guest lecturer on healthcare management issues to graduate students at major California universities.

Ana Gupte has over 20 years of healthcare experience across sell-side equity research, management consulting, corporate strategy & business development. She brings a thought leading 360-degree perspective on US healthcare spanning Managed Care, Healthcare Facilities, Pharmacy Benefits Managers (PBMs), Chain Drug Stores and the Supply Chain and Emerging Healthcare Technology Ana is a well-recognized equity research analyst in Healthcare Services, both on fundamental thought leadership, and the dynamic policy environment through the passage of ObamaCare, privatization of Medicare to Medicare Advantage, Part D, Managed Medicaid, and drug pricing reform.

Most recently her career spans 12 years of experience as a leading Wall Street sell side equity research analyst. From 2013-2019, she covered 20+stocks across Managed Care, PBMs, Chain Drug stores, Healthcare Facilities, Emerging Healthcare Technology and Healthcare policy for the Equity Research Firm and Investment Bank of SVB Leerink. Previously, she spent close to 6 years as Vice President and Senior Research Analyst, Managed Care at Sanford C. Bernstein.

Prior to her Wall Street career, Ana Gupte served as Managing Director, Enterprise Strategy & BD for Aetna. She led the organization’s Technology enabled Total Cost of Care strategy, and the 50-65 Early Retiree insurance initiative which culminated in the under-65 AARP relationship, in close partnership with the CEO and C-suite. From 2001-2005, Dr. Gupte was Executive Director and Head of Worldwide Drug Development Strategy at Pfizer, where she led a team to maximize the speed, cost and productivity of Pfizer’s Drug Development efforts across multiple therapeutic areas.

Prior to her Corporate strategy experience, Ana was a healthcare strategy consultant from 1998-2001 at the management consulting firm McKinsey & Company, where she conducted senior leadership engagements in the Pharmaceutical & Medical Devices industry. Her work spanned deal due diligence for the OTC division of a major pharmaceutical conglomerate, product launch for a new therapeutic class of anti-hypertensive, merger integration for two large pharmaceutical companies and improved managed care access for the U.S. diabetes franchise of a multi-national.

Ana Gupte was recognized as a Top 3 Analyst in the Institutional Investor 2011 and 2012 All America Research Team and Runner-Up in the 2010 Survey. In the 2016 All-America Research Team rankings, she achieved a Runner-Up ranking in Health Care Facilities & Managed Care. She was also named the Top Stock Picker in Healthcare Providers and Services for FT Thomson StarMine for 2012.

Ana is a frequent contributor to CNBC, Bloomberg TV and is widely quoted in print media including WSJ, Barron’s, Forbes, and the NY Times. She has been a keynote speaker and panelist in multiple nationally recognized healthcare industry and policy conferences including HLTH, Wall Street Comes to Washington, the National Association of State Health Policy (NASHP), and as speaker to public and not-for-profit industry Boards. Ana serves as a guest lecturer for the Healthcare MBA class at the Wharton Business School.

Ana earned a B.S in Chemical Engineering from the Bombay University, M.S. in Biochemical Engineering and Ph.D. in Biomedical Engineering from Pennsylvania State University. She has graduated from the two-year Executive Management program at the Wharton Business School.

John advises healthcare and life sciences companies on M&A, licensing and financial strategy. He also speaks frequently on topics in healthcare valuation, deal term benchmarking, and exit strategy.

WaveEdge Capital is a healthcare investment bank advising companies across the healthcare space. Prior to forming WaveEdge, John was a Managing Director at Woodside Capital Partners, a boutique investment bank and co-led the Healthcare Group. For the prior 12 years, he advised both Fortune 100 and VC-backed healthcare companies on transaction strategy and valuation at Strategic Decisions Group (SDG), a global management consulting firm, and Keelin Reeds Partners, a life sciences and healthcare management consulting firm, where he was a Principal. Prior to consulting, John was an attorney with Weil, Gotshal and Manges LLP where he focused on M&A and corporate finance.

John holds a JD from Stanford Law School and a BA from Brown University.

Tom Scully is a General Partner with Welsh, Carson, Anderson & Stowe, a private equity firm in New York, which is the most active US PE investor in healthcare. Tom joined the firm in 2004.

Mr. Scully was the Administrator of the Centers for Medicare & Medicaid Services (CMS), from 2001 to 2004. CMS administers Medicare, Medicaid, SCHIP, and is the largest agency in the U.S. Government, controlling more than $1.4 trillion a year.

At CMS, Mr. Scully had an instrumental role in designing and passing Medicare Part D and Medicare Advantage legislation. He initiated the first public reporting and disclosure for comparative quality among hospitals, nursing homes, home health agencies and dialysis centers.
Before joining CMS, Tom served as President and CEO of the Federation of American Hospitals from 1995 to 2001. The FAH represents 1500 privately owned hospitals.

Mr. Scully was a Senior Counsel with Alston & Bird 2004 - 2017; Deputy Assistant to the President and Counselor to the Director OMB, 1992-93; and an Associate Director of OMB, 1989-92. Tom worked on the Bush for President campaign in 1988; practiced law with Akin Gump from 1985-1988; Patton Boggs, LLP 1993-95 and served with US Senator Slade Gorton (WA), 1980-1985.